Outcomes following calcium channel blocker exposures reported to a poison information center
- PMID: 30482251
- PMCID: PMC6258306
- DOI: 10.1186/s40360-018-0271-9
Outcomes following calcium channel blocker exposures reported to a poison information center
Abstract
Background: Calcium channel blockers (CCBs) are widely used drugs that have a narrow therapeutic index. Even minor overdoses must be treated in-hospital due to the risk of severe hypotension and bradycardia. We aimed to describe trends in CCB use and overdoses in Denmark.
Methods: Data on enquiries concerning CCBs reported to the Danish Poisons Information Center (DPIC) from January 2009 to January 2015 was coupled with data on hospitalization and mortality obtained from Danish National Registers. We obtained data on the general use of CCBs in Denmark and retrieved medical charts on fatal cases.
Results: From a total of 126,987 enquiries to the DPIC in 2009-2014 we identified 339 CCB unique exposures (3‰ of all). Children < 5 years accounted for 20% all exposures and these were classified as 'intake during playing' (61%) and 'medication errors' (39%). Among adults 'suicidal poisonings' (58%), and 'medication errors' (34%) were most frequent. A majority (81%) of exposures led to hospital admission. Seven patients (2%) died from the CCB exposure and all were adults with 'suicidal poisoning'. Amlodipine accounted for 95% of all CCB prescriptions, was involved in 71% of enquiries and in 29% of fatalities. Verapamil accounted for 3% of prescriptions, was involved in 13% of enquiries and 57% of fatalities.
Conclusion: Four fifths of enquiries to the DPIC result in hospitalization and one fifth concern small children. Mortality were infrequent and occurred only in adults with suicidal exposures and with and an overrepresentation of verapamil exposures.
Keywords: Amlodipin; Calcium antagonist; Calcium channel blockers; Diltiazem; Felodipin; Isradipin; Lacidipin; Lercanidipin; Nifedipin; Nimodipin; Nitrendipin; Overdose; Poisoning; Verapamil.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by the Danish Data Protection Agency (2012-58-0004). In Denmark, the Act on Processing of Personal Data does not require obtained consent or ethical approval for anonymized retrospective registry studies. The Danish Patient Safety Authority approved (journal number 3–3013-1382/1) the retrieval of data from the DPIC database and from the local clinical departments, who forwarded then forwarded the clinical data from medical charts on non-anonymous poisoned patients.
Consent for publication
Not applicable. In Denmark, the Act on Processing of Personal Data does not require obtained consent or ethical approval for anonymized retrospective registry studies.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures




Similar articles
-
Calcium channel blocker overdose: Not all the same toxicity.Br J Clin Pharmacol. 2025 Mar;91(3):740-747. doi: 10.1111/bcp.16258. Epub 2024 Sep 21. Br J Clin Pharmacol. 2025. PMID: 39305202 Free PMC article.
-
Pharmaceutical-Related Poisonings in Greenland.Basic Clin Pharmacol Toxicol. 2025 Apr;136(4):e70016. doi: 10.1111/bcpt.70016. Basic Clin Pharmacol Toxicol. 2025. PMID: 40051025 Free PMC article.
-
Overdoses with Aripiprazole: Signs, Symptoms and Outcome in 239 Exposures Reported to the Danish Poison Information Centre.Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):293-298. doi: 10.1111/bcpt.12902. Epub 2017 Oct 11. Basic Clin Pharmacol Toxicol. 2018. PMID: 28881461
-
A 10-year review of single medication double-dose ingestions in the nation's largest poison control system.Clin Toxicol (Phila). 2019 Jan;57(1):31-35. doi: 10.1080/15563650.2018.1493205. Epub 2018 Nov 28. Clin Toxicol (Phila). 2019. PMID: 30484705 Review.
-
Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers.Am J Health Syst Pharm. 2006 Oct 1;63(19):1828-35. doi: 10.2146/ajhp060041. Am J Health Syst Pharm. 2006. PMID: 16990629 Review.
Cited by
-
Calcium Channel Blocker Toxicity: A Practical Approach.J Multidiscip Healthc. 2022 Aug 30;15:1851-1862. doi: 10.2147/JMDH.S374887. eCollection 2022. J Multidiscip Healthc. 2022. PMID: 36065348 Free PMC article. Review.
-
Vasopressor Use, Critical Care Management, and Outcomes in Dihydropyridine Calcium Channel Blocker Toxicity.J Med Toxicol. 2025 Jul;21(3):304-311. doi: 10.1007/s13181-025-01069-6. Epub 2025 Apr 11. J Med Toxicol. 2025. PMID: 40214921
-
Uncovering the Hidden Burden of Pharmaceutical Poisoning in High-Income and Low-Middle-Income Countries: A Scoping Review.Pharmacy (Basel). 2023 Nov 24;11(6):184. doi: 10.3390/pharmacy11060184. Pharmacy (Basel). 2023. PMID: 38133459 Free PMC article.
-
Antihypertensive agents: a long way to safe drug prescribing in children.Pediatr Nephrol. 2020 Nov;35(11):2049-2065. doi: 10.1007/s00467-019-04314-7. Epub 2019 Nov 1. Pediatr Nephrol. 2020. PMID: 31676933 Free PMC article. Review.
-
Hemoadsorption Therapy for Calcium Channel Blocker Overdose at a Tertiary-level Intensive Care Unit: A Retrospective Study.Indian J Crit Care Med. 2025 Feb;29(2):130-136. doi: 10.5005/jp-journals-10071-24906. Epub 2025 Jan 31. Indian J Crit Care Med. 2025. PMID: 40110160 Free PMC article.
References
-
- Olson Kent R., Erdman Andrew R., Woolf Alan D., Scharman Elizabeth J., Christianson Gwenn, Caravati E. Martin, Wax Paul M., Booze Lisa L., Manoguerra Anthony S., Keyes Daniel C., Chyka Peter A., Troutman William G. Calcium Channel Blocker Ingestion: An Evidence-Based Consensus Guideline for Out-of-Hospital Management. Clinical Toxicology. 2005;43(7):797–822. doi: 10.1080/15563650500357404. - DOI - PubMed
-
- Hoffman RS, Howland MA, Lewin NA, Nelson L, Goldfrank LR, Flomenbaum N, redaktører. Goldfrank’s toxicologic emergencies. Tenth edition. New York: McGraw-hill Education; 2015. 1882 s.
-
- Levine Michael, Boyer Edward W., Pozner Charles N., Geib Ann-Jeannette, Thomsen Todd, Mick Nathan, Thomas Stephen H. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil*. Critical Care Medicine. 2007;35(9):2071–2075. doi: 10.1097/01.CCM.0000278916.04569.23. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources